Shed

What Shed does

Shed, operating also as ShedRx, is a US-based direct-to-consumer telehealth platform founded in 2022 and headquartered in Salt Lake City, Utah. The company provides online prescribing, fulfillment, and ongoing care for GLP-1 weight loss medications (compounded semaglutide and tirzepatide, oral GLP-1 drops and lozenges, Foundayo/orforglipron, and FDA-approved Wegovy and Zepbound), with adjacent lines in longevity and vitality (NAD+, glutathione, methylene blue, low-dose naltrexone, sermorelin, microdose GLP-1), sexual health (Rise, Steady, Extend for men; Desire, Euphoria for women), and hair loss (men's and women's minoxidil/finasteride, copper peptide serums).

The underlying technology stack is a telemedicine platform supporting asynchronous digital intake, provider review, and prescription issuance, paired with a member portal (portal.tryshed.com) for prescription management and a free mobile application, Pivot, for GLP-1 dose and side-effect tracking. The model is 100% online, requiring no in-person visits, with medications shipped directly to members. Supporting services include AI-assisted text-based health coaching with human coach oversight, a Shed Community platform, and a Shed Supplements sub-brand for over-the-counter nutritional products.

The business model is subscription-recurring. Shed monetizes through monthly medication subscriptions priced from $43 (hair) to $349 (premium GLP-1 tiers), a separate Shed membership covering unlimited provider visits and community access, and add-on health coaching services. Longer 6- and 12-month commitments carry discounts of $180 to $720. The go-to-market motion is product-led growth via a self-serve online funnel, content marketing (Shed Blog covering GLP-1s, longevity, hormones, and nutrition), paid and organic social across Facebook, Instagram, TikTok, YouTube, and X, earned media in Forbes Health and CNN, email nurturing, and a member referral program. Target segments are US adults seeking chronic weight management, healthy aging, hair regrowth, and sexual health solutions.

Name

Shed

Legal name

Shed

Website

https://tryshed.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Shed is a US-based direct-to-consumer telehealth platform offering online prescribing and home delivery of GLP-1 weight loss medications plus longevity, sexual health, and hair loss treatments to individual subscribers on a monthly subscription model.

Ownership category

akta.pro rank

Product category

Telehealth Weight Management

NAICS

Diet and Weight Reducing Centers (812191)

SIC

Services-Home Health Care Services (8082)

akta.pro primary industry

Weight Loss Coaching (Non-Clinical) (HSADAFAB)

akta.pro secondary industry

Healthy Aging & Longevity Lifestyle Coaching (HSADAGAK)

Keywords

• Telehealth weight loss
• GLP-1 medications
• Online wellness platform
• Compounded semaglutide
• Direct-to-consumer pharmacy

Headquarters

HQ city

Not specified

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Supply Chain

Revenue model

1. Monthly Medication Subscriptions: Recurring monthly subscriptions for GLP-1 medications (compounded semaglutide, tirzepatide, and brand-name options), hair loss treatments, longevity medications, and sexual health products. Medications are billed monthly with options for 1, 6, or 12-month commitment plans with discounts for longer terms.
2. Shed Membership Program: Monthly membership covering unlimited provider visits, access to Shed Community, educational courses, nutrition plans, health coaching, and ongoing support. Medication costs are separate from membership fees.
3. Health Coaching Add-on: Additional coaching services for personalized habit building and lifestyle support, complementing medication treatments

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Shed is a direct-to-consumer telehealth company that connects adult members with licensed providers who prescribe and ship GLP-1 weight loss medications, longevity and metabolic support therapies, sexual health treatments, and hair regrowth products. The end-to-end experience runs online: members complete a digital health form, receive asynchronous physician review, and have compounded or FDA-approved prescriptions delivered to their home alongside health coaching, community resources, and the Pivot tracking app.

Product overview

Shed is a telehealth wellness company offering a comprehensive platform for GLP-1-based weight loss and broader health solutions. The platform combines prescription medications (including compounded and FDA-approved options), health coaching, tracking tools, and community support. The core product portfolio spans four main categories: (1) GLP-1 Weight Loss Solutions including Compounded Tirzepatide, Compounded Semaglutide, GLP-1 Liquid Drops, GLP-1 Lozenges, Foundayo oral pill, Wegovy, and Zepbound; (2) Longevity/Vitality products including Microdose GLP-1, Glutathione, Methylene Blue, NAD+, Low-Dose Naltrexone, and Sermorelin; (3) Sexual Health products for men (Rise, Steady, Extend) and women (Desire, Euphoria); (4) Hair Loss Solutions for men and women including Minoxidil+Finasteride formulations, multi-ingredient hair tablets and serums, and Copper Peptide treatments. Supporting services include Health Coaching, the Pivot tracking app, Shed Community, and Member Portal.

Differentiator

Problem solved

Functional benefit

Brands

• Shed Supplements: A line of nutritional supplements including protein powders, greens, collagen peptides, and magnesium supplements.
• Pivot

Products and services

• Compounded Tirzepatide Injections

Quantifiable outcome

• 15-20% body weight loss potential with GLP-1 treatment
• +3 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Hims & Hers Health: Public telehealth consumer platform offering weight-loss (including GLP-1s), hair loss, sexual health, and wellness subscriptions via direct-to-consumer online model. Closest scaled analog to Shed's four-vertical, cash-pay, subscription-led structure.
• Ro: Direct-to-consumer telehealth company (formerly Roman) offering weight management via GLP-1s plus men's and women's health verticals. Operates the same online-only, subscription-based model with provider network as Shed.
• Found: Telehealth weight-loss platform pairing GLP-1 prescriptions with behavior coaching and provider oversight on a subscription basis. Targets the same adults-with-obesity segment Shed serves, with comparable asynchronous intake flow.
• Calibrate: Metabolic-health telehealth program combining GLP-1 medication with intensive coaching and curriculum for chronic weight management. Direct competitor to Shed's weight-loss-plus-coaching thesis.
• WeightWatchers (WW Clinic): Legacy weight-loss brand that has added GLP-1 telehealth through its WW Clinic offering. Competes with Shed on consumer brand recognition in the weight-loss category while also offering behavioral program depth.

Emerging players

• LillyDirect: Eli Lilly's direct-to-patient platform for dispensing Zepbound and other Lilly drugs, bypassing traditional telehealth intermediaries. Represents a structural threat to telehealth players like Shed by disintermediating the provider-prescriber layer.
• Noom Med: Behavior-change weight-loss platform (Noom) that has launched Noom Med to offer GLP-1 prescriptions through its existing app-based coaching relationship. Combines lifestyle coaching with medication access in a structure similar to Shed's coaching-plus-medication model.
• Mochi Health: Telehealth weight-loss platform prescribing GLP-1s with provider oversight and ongoing support. Smaller-scaled but direct competitor in the same cash-pay, subscription-based, obesity-treatment category as Shed.

Broad incumbents

• Teladoc Health: Large incumbent virtual care platform offering chronic condition management, weight management, and primary care via telehealth. Overlaps with Shed's virtual-care capability but at much broader scope and via enterprise/payer contracts.
• Novo Nordisk (Wegovy / Ozempic patient programs): Manufacturer of Wegovy and Ozempic; operates patient assistance and direct channels that compete at the supply layer. While not a direct DTC subscription brand, its pricing and supply decisions dictate economics for telehealth resellers including Shed.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/tryshed
• YouTubeyoutube.com/@try_shed
• Facebookfacebook.com/tryshed
• Instagraminstagram.com/tryshed
• TikToktiktok.com/@tryshed?lang=en
• LinkedInlinkedin.com/company/tryshed

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shed